ROCKVILLE, Md., April 30 /PRNewswire/ -- BioReliance Corporation announced today that David Onions, Ph.D., has been appointed Chief Scientific Officer, effective June 18, 2007. Dr. Onions will be responsible for leading BioReliance's global scientific efforts across preclinical and clinical activities, including the development of enhanced assay systems, consulting with key customers and partnering with regulatory agencies. Dr. Onions will be joining BioReliance from Invitrogen Corporation where he has held the role of Chief Medical Officer since 2005.
